Solid Biosciences and SGT-212 gene therapy updates
In people with FA, a protein called frataxin is reduced. SGT-212, developed by pharmaceutical company Solid Biosciences, is designed to deliver frataxin to both the cerebellum in the brain, and […]
Solid Biosciences and SGT-212 gene therapy updates Read More »